Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ARDELYX, INC. (ARDX)

Ardelyx Q2 product revenue rises 31% to $118.1 million; IBSRELA 2026 guidance cut

Mixed Impact 4 of 5 guidance Written later

Ardelyx reported second-quarter 2026 total product revenue of $118.1 million, up 31% from a year earlier, and a narrower net loss of $16.7 million, or $(0.07) per share. The company cut its full-year 2026 IBSRELA revenue guidance to $350 million to $370 million from $410 million to $430 million, and withdrew its long-term XPHOZAH guidance, citing payor access barriers and evolving market dynamics that matter to shareholders' view of growth timing.

Key points

  • Q2 2026 total product revenue was $118.1 million, up from $90.1 million; IBSRELA $86.2 million (up 33%) and XPHOZAH $31.9 million (up 27%).
  • Net loss narrowed to $16.7 million, or $(0.07) per share, from $19.1 million, or $(0.08) per share, a year earlier.
  • FY 2026 IBSRELA revenue guidance revised to $350 million to $370 million from $410 million to $430 million; XPHOZAH FY 2026 guidance reiterated at $110 million to $120 million.
  • Operating expense guidance lowered to below $500 million from up to $520 million; long-term XPHOZAH guidance withdrawn and timing of the $1 billion IBSRELA target under evaluation.

The filing

CompanyARDELYX, INC. (ARDX)
Form8-K, current report
Filed with the SECAug 6, 2026, 4:09 PM ET
Accession number0001437402-26-000043

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.